Traders Buy High Volume of Call Options on Imperva (IMPV)

Imperva Inc (NASDAQ:IMPV) was the recipient of unusually large options trading activity on Monday. Stock traders bought 1,059 call options on the company. This is an increase of approximately 1,758% compared to the typical volume of 57 call options.

A number of institutional investors and hedge funds have recently bought and sold shares of IMPV. Carillon Tower Advisers Inc. bought a new stake in Imperva in the 4th quarter valued at $36,802,000. Alyeska Investment Group L.P. lifted its position in Imperva by 89.3% in the 3rd quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock valued at $39,390,000 after acquiring an additional 428,163 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its position in Imperva by 171.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 475,000 shares of the software maker’s stock valued at $20,702,000 after acquiring an additional 300,000 shares in the last quarter. Renaissance Technologies LLC lifted its position in Imperva by 55.2% in the 4th quarter. Renaissance Technologies LLC now owns 798,100 shares of the software maker’s stock valued at $31,685,000 after acquiring an additional 283,700 shares in the last quarter. Finally, BlackRock Inc. lifted its position in Imperva by 11.3% in the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after acquiring an additional 215,170 shares in the last quarter. 93.61% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms have commented on IMPV. Piper Jaffray Companies raised shares of Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 target price for the company in a report on Friday, February 9th. JPMorgan Chase & Co. lowered shares of Imperva from a “neutral” rating to an “underweight” rating and set a $45.00 price target for the company. in a report on Tuesday, December 12th. Zacks Investment Research lowered shares of Imperva from a “buy” rating to a “hold” rating in a report on Wednesday, January 10th. Imperial Capital boosted their price target on shares of Imperva from $50.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, February 9th. Finally, KeyCorp reissued a “hold” rating on shares of Imperva in a report on Tuesday, October 24th. Three analysts have rated the stock with a sell rating, five have given a hold rating and eleven have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $52.93.

Imperva (NASDAQ:IMPV) remained flat at $$46.00 on Wednesday. 491,125 shares of the company’s stock were exchanged, compared to its average volume of 387,813. The firm has a market capitalization of $1,560.00, a P/E ratio of 68.66 and a beta of 1.79. Imperva has a one year low of $37.17 and a one year high of $52.40.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings data on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating the consensus estimate of $0.27 by $0.13. The business had revenue of $91.10 million for the quarter, compared to analysts’ expectations of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.37%. The firm’s revenue was up 16.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 EPS. research analysts expect that Imperva will post -0.82 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Traders Buy High Volume of Call Options on Imperva (IMPV)” was first published by Markets Daily and is owned by of Markets Daily. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.themarketsdaily.com/2018/02/15/traders-buy-high-volume-of-call-options-on-imperva-impv.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply